The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial*
Joseph A. Carcillo(University of Pittsburgh), Carol Nicholson(National Institutes of Health), John Berger(Children's National), Richard Holubkov(University of Utah), Jerry J. Zimmerman(Seattle Children's Hospital), K.J.S. Anand(Stanford University), Kathleen L. Meert(Central Michigan University), Jeri Burr(University of Utah), Christopher J. L. Newth(University of Southern California), Douglas F. Willson(Virginia Commonwealth University), J. Michael Dean(University of Utah), Rick Harrison
Cited by 89
Related Papers
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858
American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock
|Critical Care Medicine|2017|679